NewsBenzinga花旗维持对阿里巴巴集团控股的买入评级，并将目标价上调至193美元 花旗维持对阿里巴巴集团控股的买入评级，并将目标价上调至193美元 Benzinga 2026.10.08 21:32 (GMT+0) Open on Benzinga Other news Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34 Leerink Partners Initiates Coverage On Nektar Therapeutics with Outperform Rating, Announces Price Target of $130 Salesforce Agrees To Acquire AI-Powered Analytics Platforms Loops; Financial Terms Undisclosed Amazon To $310? Here Are 10 Top Analyst Forecasts For Monday FNB Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call What's Going On With Fastly Stock Monday?
Leerink Partners Initiates Coverage On Vera Therapeutics with Market Perform Rating, Announces Price Target of $34
Leerink Partners Initiates Coverage On Nektar Therapeutics with Outperform Rating, Announces Price Target of $130
